Protara Therapeutics (TARA) CFO Fabbio gave up 3,061 shares at $4.76 to cover taxes or an exercise price
Insider transactions reported
Patrick Fabbio (Chief Financial Officer at Protara Therapeutics Inc., TARA) reported that they gave up 3,061 shares at $4.76 to cover taxes or an exercise price on Jan 21, 2025. After these transactions the filing shows 18,939 shares held directly.
- Reporting person
- Fabbio Patrick
- Role
- Chief Financial Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock1 | -3,061 | $4.76 | $14.6K | 18,939 direct |
Holdings before and after
- Common Stock: 22,000 to 18,939 direct
Footnotes from the filing
- 1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Fabbio report in this TARA Form 4?
Patrick Fabbio (Chief Financial Officer at Protara Therapeutics Inc., TARA) reported that they gave up 3,061 shares at $4.76 to cover taxes or an exercise price on Jan 21, 2025. After these transactions the filing shows 18,939 shares held directly.
How many TARA shares does Fabbio hold after this filing?
The filing shows 18,939 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for TARA
Earlier insider filings at TARA
- Jan 23, 2025VP, Controller Fry Hannah covered exercise/tax liability with 2,130 shares, decreasing direct ownership by 7% to 27,312 units (SEC Form 4)
- Jan 23, 2025Chf Scientific Operations Off Zummo Jacqueline covered exercise/tax liability with 6,554 shares, decreasing direct ownership by 6% to 95,585 units (SEC Form 4)
- Jan 7, 2025CEO and President Shefferman Jesse covered exercise/tax liability with 6,479 shares, decreasing direct ownership by 0.69% to 929,022 units (SEC Form 4)
- Jan 7, 2025Chf Scientific Operations Off Zummo Jacqueline covered exercise/tax liability with 2,157 shares, decreasing direct ownership by 2% to 102,139 units (SEC Form 4)
- Jan 7, 2025VP, Controller Fry Hannah covered exercise/tax liability with 394 shares, decreasing direct ownership by 1% to 29,442 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2014
Follow TARA and get a push notification the moment its next story breaks.